Author: B. Dungu, M. Donadeu, M.Bouloy
Year: 2013
About this Publication:
Vaccination continues to be the most effective way to control Rift Valley fever (RVF), a zoonotic insect-borne viral disease of livestock. The irregular, cyclical and persistent nature of RVF in its occurrence in enzootic situations suggests that the vaccination strategy to be considered for these regions should be different from what is envisaged for free from risk regions. Currently available RVF vaccines have been extensively used for the control of the disease. However, these vaccines have shortcomings that have encouraged many research groups to develop new vaccine candidates that would address a large number of the current challenges, and be suitable for use both in disease-free regions and in different contingency and emergency preparedness strategies. The characteristics of different RVF vaccines and vaccination strategies are discussed in this report.
Grant: PLSHL2
Subject Areas: Research and Development
Diseases: Rift Valley Fever
URL https://www.ncbi.nlm.nih.gov/pubmed/23689884
Keywords:
Rift Valley Fever, Vaccination
Countries:
Botswana, Comoros, Guinea, Kenya, Madagascar, Mauritania, Mozambique, Namibia, Saudi Arabia, South Africa, Sudan, Swaziland, Tanzania, United Republic Of, Yemen
